Elon Musk's brain-chip start-up, Neuralink, has successfully implanted its first chip into a human patient.
The news was announced by Musk himself, who confirmed that the patient is in good health and showing promising initial results.
Neuralink's groundbreaking technology involves a brain-computer interface (BCI) implant, surgically placed in the brain region controlling the intention to move. The goal? To allow individuals to control a computer cursor or keyboard using only their thoughts.
The U.S. Food and Drug Administration (FDA) gave Neuralink the green light last year to conduct its first human trial, a significant step towards the company's ambitious aim of helping patients overcome paralysis and various neurological conditions.
The first product from Neuralink, named Telepathy, will utilise "ultra-fine" threads to transmit signals in participants' brains. The PRIME Study, Neuralink's current trial, is evaluating the safety of the implant and the surgical robot used in the procedure.
However, Neuralink's journey hasn't been without controversy. The company has faced scrutiny over its safety protocols and was recently fined for violating U.S. Department of Transportation rules. Despite these challenges, Neuralink continues to forge ahead, aiming to revolutionise neurotechnology and change the way we interact with technology forever.
As we watch this space, one thing is clear: the future of brain tech is here, and it's more exciting than ever.
Made with TRUST_AI - see the Charter: https://www.modelprop.co.uk/trust-ai
Comments